BioMarin Pharmaceutical Inc.
USD53.32
-1.71 (-3.11%)
CEO
Alexander Hardy
IPO Date
1999-07-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$54.09
Prev. Close
$55.03
Day Low
$53.28
Day High
$55.05
52W Low
$49.26
52W High
$66.28
Market Cap
$10.31B
Volume
2.71M
| 3,281 |
| $53.85 |
| 19 Mar 2026 | Davis George Eric | EVP, Chief Legal Officer | F-InKind | Disposed | 1,273 | $56.05 |
| 19 Mar 2026 | Guyer Charles Greg | EVP, Chief Technical Officer | F-InKind | Disposed | 1,693 | $56.05 |
| 19 Mar 2026 | Mueller Brian | EVP, Chief Financial Officer | F-InKind | Disposed | 2,117 | $56.05 |
| 19 Mar 2026 | Hardy Alexander | director, officer: Chief Executive Officer | F-InKind | Disposed | 4,252 | $56.05 |
| 18 Mar 2026 | Hubbard Cristin | EVP, Chief Commercial Officer | A-Award | Acquired | 15,410 | $0.00 |
| 18 Mar 2026 | Hubbard Cristin | EVP, Chief Commercial Officer | F-InKind | Disposed | 1,245 | $56.05 |
| 18 Mar 2026 | Hubbard Cristin | EVP, Chief Commercial Officer | A-Award | Acquired | 36,680 | $57.43 |
| 18 Mar 2026 | Friberg Gregory R | EVP, Chief R&D Officer | A-Award | Acquired | 19,150 | $0.00 |
| 10 Jun 2022 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 15 Nov 2021 | Josh Gottheimer | Josh Gottheimer | Sale (Full) | $1,001 - $15,000 |
| 11 Jan 2021 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $15,001 - $50,000 |
| 5 Nov 2020 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 13 Oct 2020 | Josh Gottheimer | Josh Gottheimer | Sale (Full) | $1,001 - $15,000 |
| 6 Jan 2020 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 6 Jan 2020 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |